The Anti Fungal Pipeline in Drugs

The next major trial that came out was the phase three randomized double blind non inferiority trial of pose a console versus worry connozzle for the primary treatment of invasive aspergiliosis. We developed 575 patients from 26 countries with proven probable or suspected invasive as pergiliosis and we ended this to only patients with proven or probable disease it was 19% in each arm. Treatment related adverse events were greater in the worry Connozzle arm 40% versus 30%. And these were largely driven by neuro toxicity so hallucinations and things like that which I think we've all seen in our patients on worryConnie. So overall what we need to know about this trial is it's a

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app